Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.

Ling S, Lewanczuk RZ, Russell AS, Ihejirika B, Jamali F.

J Clin Pharmacol. 2009 Mar;49(3):301-11. doi: 10.1177/0091270008328099. Epub 2009 Jan 23.

PMID:
19168802
[PubMed - indexed for MEDLINE]
2.

Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis.

Mayo PR, Skeith K, Russell AS, Jamali F.

Br J Clin Pharmacol. 2000 Dec;50(6):605-13.

PMID:
11136300
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.

Ling S, Jamali F.

Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):24-9. doi: 10.1111/j.1742-7843.2009.00405.x. Epub 2009 Apr 3.

PMID:
19371259
[PubMed - indexed for MEDLINE]
4.

Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gonzalez-Juanatey C, de Matias JM, Martin J, Dessein PH, Llorca J.

Clin Exp Rheumatol. 2009 May-Jun;27(3):452-8.

PMID:
19604438
[PubMed - indexed for MEDLINE]
5.

Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.

Cardillo C, Schinzari F, Mores N, Mettimano M, Melina D, Zoli A, Ferraccioli G.

Clin Pharmacol Ther. 2006 Sep;80(3):275-81.

PMID:
16952494
[PubMed - indexed for MEDLINE]
6.

Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.

Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M.

J Autoimmun. 2008 Sep;31(2):175-9. doi: 10.1016/j.jaut.2008.07.002. Epub 2008 Aug 15.

PMID:
18707846
[PubMed - indexed for MEDLINE]
7.

Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis.

Kanbe K, Inoue K, Inoue Y, Suzuki Y.

Clin Rheumatol. 2008 Jun;27(6):777-81. doi: 10.1007/s10067-008-0850-z. Epub 2008 Feb 7.

PMID:
18256870
[PubMed - indexed for MEDLINE]
8.

The effect of infliximab on chemokines in patients with rheumatoid arthritis.

Torikai E, Kageyama Y, Suzuki M, Ichikawa T, Nagano A.

Clin Rheumatol. 2007 Jul;26(7):1088-93. Epub 2006 Nov 17.

PMID:
17111092
[PubMed - indexed for MEDLINE]
9.

Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis.

Kanbe K, Inoue K, Inoue Y, Suzuki Y.

Clin Rheumatol. 2008 Apr;27(4):497-501. Epub 2007 Nov 27.

PMID:
18060342
[PubMed - indexed for MEDLINE]
10.

Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.

Odai T, Matsunawa M, Takahashi R, Wakabayashi K, Isozaki T, Yajima N, Miwa Y, Kasama T.

J Rheumatol. 2009 Jun;36(6):1158-65. doi: 10.3899/jrheum.081074. Epub 2009 Apr 15.

PMID:
19369458
[PubMed - indexed for MEDLINE]
11.

Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.

Kopp S, Alstergren P, Ernestam S, Nordahl S, Bratt J.

Scand J Rheumatol. 2006 May-Jun;35(3):182-8.

PMID:
16766364
[PubMed - indexed for MEDLINE]
12.

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P.

J Rheumatol. 2009 Apr;36(4):724-30. doi: 10.3899/jrheum.080626. Epub 2009 Feb 27.

PMID:
19273452
[PubMed - indexed for MEDLINE]
13.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
[PubMed - indexed for MEDLINE]
14.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
[PubMed - indexed for MEDLINE]
15.

Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy.

Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA.

Arthritis Rheum. 2008 Dec 15;59(12):1821-4. doi: 10.1002/art.24308.

PMID:
19035415
[PubMed - indexed for MEDLINE]
Free Article
16.

Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Sanaee F, Clements JD, Waugh AW, Fedorak RN, Lewanczuk R, Jamali F.

Br J Clin Pharmacol. 2011 Nov;72(5):787-97. doi: 10.1111/j.1365-2125.2011.04019.x.

PMID:
21592185
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy.

Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian OG, Borderie D.

Clin Chim Acta. 2006 Oct;372(1-2):147-53. Epub 2006 Apr 7.

PMID:
16716286
[PubMed - indexed for MEDLINE]
18.

Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis.

Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, Martin J, Dessein PH, Llorca J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):311-6.

PMID:
18565254
[PubMed - indexed for MEDLINE]
19.

Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.

Pavelka K, Jarosová K, Suchý D, Senolt L, Chroust K, Dusek L, Vencovský J.

Ann Rheum Dis. 2009 Aug;68(8):1285-9. doi: 10.1136/ard.2008.090860. Epub 2009 Apr 6.

PMID:
19351624
[PubMed - indexed for MEDLINE]
20.

Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.

Busse D, Templin S, Mikus G, Schwab M, Hofmann U, Eichelbaum M, Kivistö KT.

Eur J Clin Pharmacol. 2006 Aug;62(8):613-9. Epub 2006 Jul 4.

PMID:
16823584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk